Trends in Oral Anticoagulant Prescription Patterns in the Czech Republic: a Retrospective Analysis of 2019-2024
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: The patterns of oral anticoagulant (OAC) prescription have significantly changed in recent years, with direct oral anticoagulants (DOACs) gradually replacing warfarin.While this transition occurred earlier in some countries, limited data are available about its timeline in the Czech Republic.Objectives: This study aimed to analyse trends in OAC prescriptions in the Czech Republic from 2019 to 2024, focusing on the shift from warfarin to DOACs and the patterns of utilisation of individual DOACs.Methods: A retrospective analysis was conducted using national electronic prescription data from the State Institute for Drug Control (SÚKL).Annual drug consumption is presented as defined daily doses per thousand inhabitants per day (DDD/TID).Results: Total OAC utilisation increased from 18.83 to 26.70 DDD/TID between 2019 and 2024 (p < 0.01), with an average of 22.99 ± 3.05 DDD/TID.DOACs surpassed warfarin in total prescriptions in 2021.Rivaroxaban (6.84 ± 3.00 DDD/TID) and apixaban (5.24 ± 2.43 DDD/TID) exhibited the highest growth, while dabigatran utilisation (3.00 ± 0.66 DDD/TID) showed a halt in increase after 2022.Conclusion: DOACs have progressively replaced warfarin in the Czech Republic, but this transition occurred later than in other developed countries.This shift was likely influenced by local changes in prescribing restrictions.Further research is warranted to evaluate prescription patterns based on specific indications.
Source: Military Medical Science Letters
Authors: Tomas Veleta, Jiri Vlcek, Jiri Cyrany, Radovan Maly, Tomas Soukup
Institutions: Charles University, University Hospital Hradec Králové
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4409954094